Update on mechanisms of ultrafiltration failure

Peritoneal Dialysis International

Volumn 29, Issue SUPPL. 2, 2009, Pages

  Kim, Yong Lim ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

Aquaporin; Epithelial to mesenchymal transition; Ultrafiltration failure

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AQUAPORIN; AQUAPORIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; DIALYSIS FLUID; VASCULOTROPIN A;

ANGIOGENESIS; BIOCOMPATIBILITY; CELL ACTIVITY; COMORBIDITY; CONFERENCE PAPER; DISEASE COURSE; DNA POLYMORPHISM; EXTRACELLULAR MATRIX; FIBROGENESIS; GENETIC ASSOCIATION; GLUCOSE METABOLISM; HEREDITY; HUMAN; MAST CELL; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MESENCHYME CELL; MESOTHELIUM CELL; MYOFIBROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEUM CELL; PERITONITIS; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SENESCENCE; SIGNAL TRANSDUCTION; TREATMENT FAILURE; ULTRAFILTRATION; ANIMAL; BIOSYNTHESIS; CELL MEMBRANE PERMEABILITY; CHRONIC KIDNEY FAILURE; DRUG EFFECT; EPITHELIUM CELL; METABOLISM; PATHOLOGY; PERITONEUM; PHYSIOLOGY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; AQUAPORIN 1; BIOLOGICAL TRANSPORT; CELL MEMBRANE PERMEABILITY; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PERITONEUM; TRANSFORMING GROWTH FACTOR BETA; TREATMENT FAILURE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67449105022     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902902s24     Document Type: Conference Paper

References (38)

1. Honda K, Hamada C, Nakayama M, Miyazaki M, Sherif AM, Harada T, et al., on behalf of the Peritoneal Biopsy Study Group of the Japanese Society for Peritoneal Dialysis. Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol 2008; 3:720-8.
2. Kim CD, Kwon HM, Park SH, Oh EJ, Kim MH, Choi SY, et al. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model. Ther Apher Dial 2007; 11: 56-64.
3. Flessner MF, Credit K, Henderson K, Vanpelt HM, Potter R, He Z, et al. Peritoneal changes after exposure to sterile solutions by catheter. J Am Soc Nephrol 2007; 18: 2294-302.
4. WiLm B, Ipenberg A, Hastie ND, Burch JB, Bader DM. The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature. Development 2005; 132: 5317-28.
5. Yáñez-Mó M, Lara-Pezzi E, Selgas R, Ramírez-Huesca M, Domínguez-Jiménez C, Jiménez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348:403-13.
6. Margetts PJ, Bonniaud P, Liu L, Hoff CM, Holmes CJ, West-Mays JA, et al. Transient overexpression of TGF-β1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 2005; 16:425-36.
7. De Vriese AS, Tilton RG, Mortier S, Lameire NH. Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. Nephrol Dial Transplant 2006; 21:2549-55.
8. Boulanger E, Grossin N, Wautier MP, Taamma R, Wautier JL. Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation. Kidney Int 2007; 71:126-33.
9. Kihm LP, Wibisono D, Muller-Krebs S, Pfisterer F, Morath C, Gross ML, et al. RAGE expression in the human peritoneal membrane. Nephrol Dial Transplant 2008;23:3302-6.
10. Lee DH, Choi SY, Ryu HM, Kim CD, Park SH, Chung HY, et al. 3,4-Dideoxyglucosone-3-ene induces apoptosis in human peritoneal mesothelial cells. Perit Dial Int; [In press].
11. Leung JC, Chan LY, Tang SC, Chu KM, Lai KN. Leptin induces TGF-β synthesis through functional leptin receptor expressed by human peritoneal mesothelial cell. Kidney Int 2006; 69:2078-86.
12. Yang AH, Huang SW, Chen JY, Lin JK, Chen CY. Leptin augments myofibroblastic conversion and fibrogenic activity of human peritoneal mesothelial cells: a functional implication for peritoneal fibrosis. Nephrol Dial Transplant 2007; 22:756-62.
13. Aroeira LS, Aguilera A, Selgas R, Ramírez-Huesca M, Pérez-Lozano ML, Cirugeda A, et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 2005; 46:938-48.
14. Del Peso G, Jimenez-Heffernan JA, Bajo MA, Aroeira LS, Aquilera A, Fernandez-Perpen A, et al. Epithelial-to-mesenchymal transition of mesothelial cells in an early event during peritoneal dialysis and is associated with high peritoneal transport. Kidney Int Suppl 2008; (108):S26-33.
15. Vargha R, Endemann M, Kratochwill K, Riesenhuber A, Wick N, Krachler AM, et al. Ex vivo reversal of in vivo trans-differentiation in mesothelial cells grown from peritoneal dialysate effluents. Nephrol Dial Transplant 2006; 21: 2943-7.
16. Szeto CC, Chow KM, Kwan BC, Lai KB, Chung KY, Leung CB, et al. The relationship between bone morphogenic protein-7 and peritoneal transport characteristics. Nephrol Dial Transplant 2008; 23:2989-94.
17. Ksiazek K, Korybalska K, Jörres A, Witowski J. Accelerated senescence of human peritoneal mesothelial cells exposed to high glucose: the role of TGF-β1. Lab Invest 2007; 87: 345-56.
18. Witowski J, Ksiazek K, Jörres A. New insights into the biology of peritoneal mesothelial cells: the roles of epithelial-to-mesenchymal transition and cellular senescence. Nephron Exp Nephrol 2008; 108:e69-73.
19. Nevado J, Vallejo S, EL-Assar M, Peiró C, Sánchez-Ferrer CF, Rodriguez-Mañas L. Changes in the human peritoneal mesothelial cells during aging. Kidney Int 2006; 69: 313-22.
20. Guo H, Leung JC, Lam MF, Chan LY, Tsang AW, Lan HY, et al. SMAD7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis. J Am Soc Nephrol 2007; 18:2689-703.
21. Park SH, Choi SY, Kim MH, Oh EJ, Ryu HM, Kim CD, et al. The TGF-β-induced gene product, Betaig-h3: its biological implications in peritoneal dialysis. Nephrol Dial Transplant 2008; 23:126-35.
22. Ni J, Verbavatz JM, Rippe A, Boisdé I, Moulin P, Rippe B, et al. Aquaporin-1 plays an essential role in water permeability and ultraffitration during peritonealdialysis. Kidney Int 2006; 69:1518-25.
23. Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 2005; 434: 786-92.
24. Verkman AS. Aquaporins in endothelia. Kidney Int 2006; 69:1120-3.
25. Zareie M, Fabbrini P, Hekking LH, Keuning ED, ter Wee PM, BeeLen RH, et al. NoveL role for mast cells in omental tissue remodeling and cell recruitment in experimental peritoneal dialysis. J Am Soc Nephrol 2006; 17:3447-57.
26. Jiménez-Heffernan JA, Bajo MA, Perna C, del Peso G, Larrubia A Gamallo C, et al. Mast cell quantification in normal peritoneum and during peritoneal dialysis treatment. Arch Pathol Lab Med 2006; 130:1188-92.
27. Alscher DM, Braun N, Biegger D, Fritz P. Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients. Am J Kidney Dis 2007; 49:452-61.
28. Chung SH, Heimbürger O, Lindholm B. Poor outcomes for fast transporters on PD: the rise and fall of a clinical concern. Semin Dial 2008; 21:7-10.
29. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Pagé D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-U.S.A. (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9:1285-92.
30. Davies SJ. Longitudinal relationship between solute transport and uLtrafiltration capacity in peritoneal dialysis patients. Kidney Int 2004; 66:2437-45.
31. Rumpsfeld M, McDonald SP, Purdie DM, Collins J, Johnson DW. Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. Am J Kidney Dis 2004; 43:492-501.
32. Gillerot G, Goffin E, Michel C, Evenepoel P, Biesen WV, Tintilier M, et al. Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 2005; 67:2477-87.
33. CLerbaux G, Francart J, Wallemacq P, Robert A, Goffin E. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up. Nephrol Dial Transplant 2006; 21:1032-9.
34. Oh KH, Moon JY, Oh J, Kim SG, Hwang YH, Kim S, et al. Baseline peritoneaL solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients. Nephrol Dial Transplant 2008; 23:2356-64.
35. Reyes MJ, Bajo MA, Hevía C, del Peso G, Ros S, de Miguel AG, et al. Inherent high peritoneal transport and ultrafiltration deficiency: their mid-term clinical relevance. Nephrol Dial Transplant 2007; 22:218-23.
36. Rodrigues AS, Martins M, Korevaar JC, SiLva S, Oliveira JC, Cabrita A, et al. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters. Am J Nephrol 2007; 27:84-91.
37. Parikova A, Smit W, Struijk DG, Krediet RT. Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with uLtrafiltration failure. Kidney Int 2006; 70:1988-94.
38. Axelsson J, Devuyst O, Nordfors L, Heimbürger O, Stenvinkel P, Lindholm B. Place of genotyping and phenotyping in understanding and potentially modifying outcomes in peritoneal dialysis patients. Kidney Int Suppl 2006; (103):S138-45.